Science of Attention
We look at people's eyes to see if they are paying attention to us. Up until the recent development of eye tracking technology we could not measure how well the eyes were attending.
Technology companies such as Meta, Microsoft, Magic Leap, Pico and soon Apple have developed AR/VR headsets that require eye tracking to put content in front of the user. Using this technology we can now measure and train your attention.
Dr Ghajar founded Neurosync and established the Stanford Brain Performance Center to accelerate the use of EYE-SYNC, eye tracking technology for attention disorders. Clinical research funded by the Department of Defense encompassed studies of normal subjects, a variety of ages, ADHD, concussion and sleep deprivation. With over 30 publications and FDA approvals for concussion and eye tracking impairment, EYE-SYNC is the leading technology to assess your attention and enable optimization.
First publications on eye tracking impairments in concussion
$36M Funding support from the Department of Defense to launch clinical trials of eye tracking in normal civilians, military, ADHD population, concussion and sleep fatigue
SyncThink (NeuroSync) established to commercialize eye tracking diagnostics and treatment
FDA clearance for EYE-SYNC eye tracking impairments
EYE-SYNC software adapted for VR goggles
FDA clearance for EYE-SYNC aide to concussion diagnosis
· Over 100K patient eye tracking records
· 17 issued US patents
· Six eye tracking assessments
· Tests are 15 to 30 seconds in duration with immediate reports
· Attention treatment/enhancement programs
· Over 30 EYE-SYNC scientific publications